Evidence map›Paper›PMID 27081647›Full record

ReviewWorld journal of clinical oncology2016

Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.

Agnès Tallet, Eric Lambaudie, Monique Cohen, Mathieu Minsat, Marie Bannier, Michel Resbeut, Gilles Houvenaeghel

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agnès TalletAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Eric LambaudieAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Monique CohenAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Mathieu MinsatAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Marie BannierAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Michel ResbeutAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.
Gilles HouvenaeghelAgnès Tallet, Mathieu Minsat, Michel Resbeut, Departement of Radiotherapy, Institut Paoli Calmettes and CRCM, 13009 Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of sentinel lymph-node technique has led to a shift in lymph-node staging, due to the emergence of new entities namely micrometastases (pN1mi) and isolated tumor cells [pN0(i+)]. The prognostic significance of this low positivity in axillary lymph nodes is currently debated, as is, therefore its management. This article provides updates evidence-based medicine data to take into account for treatment decision-making in this setting, discussing the locoregional treatment in pN0(i+) and pN1mi patients (completion axillary dissection, axillary irradiation with or without regional nodes irradiation, or observation), according to systemic treatment, with the goal to help physicians in their daily practice.

Indexed as

Axillary lymph node dissectionBreast cancerIsolated tumor cellsMicrometastasesRadiotherapy

Identifiers

PMID27081647
PMCPMC4826970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.